(WJET/WFXP/YourErie.com) — A pharmaceutical corporation has issued a nationwide voluntary recall of its epinephrine syringes.

Adamis Pharmaceuticals Corporation issued the voluntary recall of its SYMJEPI (epinephrine) injection pre-filled single-dose syringes following reports of a potential manufacturing defect. US WorldMeds markets and distributes SYMJEPI in the United States.

According to a risk statement on the Food and Drug Administration (FDA) website, two different customers have complained about difficulty dispensing the product from three syringes.

Epinephrine is a medication used to treat allergic reaction emergencies.

“If a person is experiencing an allergic reaction and/or anaphylaxis and is unable to access life-saving epinephrine due to the syringe malfunction, it can lead to life threatening consequences including death,” the FDA notice said.

The recall encompasses SYMJEPI (epinephrine) Injection with the following information:

StrengthNDCLotExpiration
0.15 mg/0.3 mL78670-131-0221101Y11/30/2022
0.3 mg/0.3 mL78670-130-0221041W8/31/2022
21081W11/30/2022
21102W2/28/2023

The products are packaged in two-count pre-filled single-dose syringes per carton and were distributed nationwide to customers and/or medical facilities, the FDA notice said. The products can be identified by the label containing the US WorldMeds name and logo found at the bottom of the notice.

Consumers are being notified by email, FDA alert and via direct outreach. The FDA said consumers and institutions should stop using the products immediately and either return or discard them.

For news delivered right to you, subscribe to JET 24/FOX 66/YourErie.com’s breaking, daily news & severe weather email lists

For questions, call (888) 900-8796 or email medinfo@usworldmeds.com.